当前位置：药药网 / 药品 / 美国NDC未完成药物数据库文件(本栏目更新到2026-3-31)
药品名称： 商品名称： 药品NDC： 上市日期： -格式:2020-5-3
注册申请号： 市场分类： 活性成分： 持证企业：
 美国NDC未完成药物数据库文件21130条(本栏目更新到2026-3-31)
药品名称(分析)
商品名
药品NDC
专利人(分析)
上市日期
活性成分
市场分类
规格(分析)
申请号
ACETAMINOPHEN, ASPIRIN, CAFFEINE
DRUG FOR FURTHER PROCESSING
10267-5005
Contract Pharmacal Corp.
20170515
ACETAMINOPHEN; ASPIRIN; CAFFEINE
DRUG FOR FURTHER PROCESSING
250; 250; 65
10267-5005_3014c5c0-0ef1-fd22-e063-6294a90a0a55
Magnesium Salicylate, Caffeine
DRUG FOR FURTHER PROCESSING
10267-5008
Contract Pharmacal Corp.
20171011
CAFFEINE; MAGNESIUM SALICYLATE
DRUG FOR FURTHER PROCESSING
50; 162.5
10267-5008_1ddca6f8-50a8-1241-e063-6394a90a2111
Caffeine
DRUG FOR FURTHER PROCESSING
10267-5010
Contract Pharmacal Corp.
20170504
CAFFEINE
DRUG FOR FURTHER PROCESSING
100
10267-5010_3e505706-f093-d325-e063-6294a90a0d6b
Acetaminophen and Pamabrom
DRUG FOR FURTHER PROCESSING
10267-5511
Contract Pharmcal Corp.
20191029
ACETAMINOPHEN; PAMABROM
DRUG FOR FURTHER PROCESSING
500; 25
10267-5511_ee9e7a50-05cd-e9f2-e053-2995a90a8f10
Acetaminophen, Caffeine
DRUG FOR FURTHER PROCESSING
10267-5808
Contract Pharmacal Corp.
20241010
ACETAMINOPHEN; CAFFEINE
DRUG FOR FURTHER PROCESSING
500; 75
10267-5808_13b5a9fa-0447-3e86-e063-6294a90a6294
Acetaminophen
DRUG FOR FURTHER PROCESSING
10267-5923
Contract Pharmacal Corp.
20230921
ACETAMINOPHEN
DRUG FOR FURTHER PROCESSING
500
10267-5923_0c4225f6-7f2b-2c55-e063-6294a90a0145
octinoxate, titanium dioxide, and zinc oxide
DRUG FOR FURTHER PROCESSING
10348-900
SMASHBOX BEAUTY COSMETICS, INC
20230118
OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE
DRUG FOR FURTHER PROCESSING
67; 31; 13
10348-900_1d0e6718-bf47-eb18-e063-6394a90a8570
ASPIRIN
BULK INGREDIENT
10357-205
Novacyl SAS
20181001
ASPIRIN
BULK INGREDIENT
100
10357-205_ed92484a-aeed-46b2-e053-2995a90af3fd
ASPIRIN
BULK INGREDIENT
10357-209
Novacyl SAS
20181001
ASPIRIN
BULK INGREDIENT
100
10357-209_ed9274e4-0867-0713-e053-2a95a90ae88d
ASPIRIN
DRUG FOR FURTHER PROCESSING
10357-230
Novacyl SAS
20181001
ASPIRIN
DRUG FOR FURTHER PROCESSING
90
10357-230_ed9274e4-0868-0713-e053-2a95a90ae88d
ASPIRIN
DRUG FOR FURTHER PROCESSING
10357-235
Novacyl SAS
20181001
ASPIRIN
DRUG FOR FURTHER PROCESSING
90
10357-235_ed929889-90ab-e70e-e053-2a95a90af6db
ASPIRIN
DRUG FOR FURTHER PROCESSING
10357-238
Novacyl SAS
20181001
ASPIRIN
DRUG FOR FURTHER PROCESSING
89.3
10357-238_ed928c29-a91e-93d2-e053-2995a90aecc2
ASPIRIN
BULK INGREDIENT
10357-240
Novacyl SAS
20200701
ASPIRIN
BULK INGREDIENT
1
10357-240_ed929889-90ac-e70e-e053-2a95a90af6db
ASPIRIN
BULK INGREDIENT
10357-306
Novacyl SAS
20181001
ASPIRIN
BULK INGREDIENT
1
10357-306_11c14abb-1572-a760-e063-6394a90a0173
ASPIRIN
BULK INGREDIENT
10357-309
Novacyl SAS
20181001
ASPIRIN
BULK INGREDIENT
1
10357-309_fad0544d-dc45-aba7-e053-6394a90a7850
ASPIRIN
BULK INGREDIENT
10357-310
Novacyl SAS
20181001
ASPIRIN
BULK INGREDIENT
1
10357-310_e767c49f-40b9-58e9-e053-2995a90ab47b
ASPIRIN
BULK INGREDIENT
10357-313
Novacyl SAS
20181001
ASPIRIN
BULK INGREDIENT
1
10357-313_e76839b8-cece-67af-e053-2a95a90afbc2
ASPIRIN
BULK INGREDIENT
10357-320
Novacyl SAS
20181001
ASPIRIN
BULK INGREDIENT
1
10357-320_e768445d-e91e-8c95-e053-2a95a90a6f62
ASPIRIN
BULK INGREDIENT
10357-323
Novacyl SAS
20181001
ASPIRIN
BULK INGREDIENT
1
10357-323_e7684a37-118e-3b2a-e053-2995a90a0f79
METHYL SALICYLATE
BULK INGREDIENT
10357-700
Novacyl SAS
20121121
METHYL SALICYLATE
BULK INGREDIENT
1
10357-700_0c7b1486-1a52-2cb8-e063-6394a90a8644
网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈
免责声明：以上所展示的信息由企业自行提供，内容的真实性、准确性和合法性由发布企业负责，医药网对此不承担任何责任。
相关链接：医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究　　客服热线：0575-83552251 / 13754370441  QQ客服：药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　浙公网安备:330683240604819103159
　医药代理商群１：药药网药品采购交流医药代理商群２：药药网药品采购交流2医药代理商群３：药药网药品采购交流3